Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 29
2024
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+4.56%
|
$173,200
$80.86 P/Share
|
|
Apr 08
2024
|
Michael Marinaro EVP & President, Surgical OU |
SELL
Open market or private sale
|
Direct |
854
-2.97%
|
$70,882
$83.14 P/Share
|
|
Mar 05
2024
|
Michael Marinaro EVP & President, Surgical OU |
SELL
Payment of exercise price or tax liability
|
Direct |
563
-1.92%
|
$46,729
$83.6 P/Share
|
|
Feb 21
2024
|
Sean Salmon EVP & President Cardiovascular |
SELL
Open market or private sale
|
Direct |
30,695
-14.61%
|
$2,609,075
$85.11 P/Share
|
|
Feb 21
2024
|
Sean Salmon EVP & President Cardiovascular |
BUY
Exercise of conversion of derivative security
|
Direct |
30,695
+12.39%
|
$2,025,870
$66.79 P/Share
|
|
Feb 01
2024
|
Jennifer M Kirk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,159
-8.07%
|
$101,992
$88.09 P/Share
|
|
Dec 19
2023
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Open market or private sale
|
Direct |
4,997
-14.74%
|
$409,754
$82.17 P/Share
|
|
Dec 11
2023
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
SELL
Payment of exercise price or tax liability
|
Direct |
1,952
-4.74%
|
$154,208
$79.35 P/Share
|
|
Dec 08
2023
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
435
-1.27%
|
$34,365
$79.27 P/Share
|
|
Dec 08
2023
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
369
-0.76%
|
$29,151
$79.27 P/Share
|
|
Dec 08
2023
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
SELL
Payment of exercise price or tax liability
|
Direct |
716
-1.75%
|
$56,564
$79.27 P/Share
|
|
Dec 08
2023
|
Sean Salmon EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
435
-0.9%
|
$34,365
$79.27 P/Share
|
|
Aug 23
2023
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Open market or private sale
|
Direct |
10,000
-17.63%
|
$830,000
$83.84 P/Share
|
|
Aug 14
2023
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Open market or private sale
|
Direct |
1,000
-2.89%
|
$83,000
$83.38 P/Share
|
|
Aug 04
2023
|
Michael Marinaro EVP & President, Surgical OU |
SELL
Open market or private sale
|
Direct |
1,352
-4.46%
|
$113,568
$84.11 P/Share
|
|
Aug 03
2023
|
Michael Marinaro EVP & President, Surgical OU |
SELL
Payment of exercise price or tax liability
|
Direct |
1,323
-4.19%
|
$111,132
$84.49 P/Share
|
|
Aug 03
2023
|
Michael Marinaro EVP & President, Surgical OU |
BUY
Grant, award, or other acquisition
|
Direct |
1,696
+5.09%
|
-
|
|
Aug 03
2023
|
Sean Salmon EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
4,369
-8.39%
|
$366,996
$84.49 P/Share
|
|
Aug 03
2023
|
Sean Salmon EVP & President Cardiovascular |
BUY
Grant, award, or other acquisition
|
Direct |
5,604
+9.71%
|
-
|
|
Aug 03
2023
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
4,693
-7.64%
|
$394,212
$84.49 P/Share
|
|
Aug 03
2023
|
Gregory L Smith EVP Global Ops & Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
6,217
+9.19%
|
-
|
|
Aug 03
2023
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
4,051
-7.13%
|
$340,284
$84.49 P/Share
|
|
Aug 03
2023
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
4,251
+6.96%
|
-
|
|
Aug 03
2023
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
4,284
-11.03%
|
$359,856
$84.49 P/Share
|
|
Aug 03
2023
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
5,168
+11.74%
|
-
|
|
Aug 03
2023
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
4,065
-7.81%
|
$341,460
$84.49 P/Share
|
|
Aug 03
2023
|
Robert John White EVP & Pres. Medical Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
5,813
+10.05%
|
-
|
|
Aug 03
2023
|
Jennifer M Kirk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
361
-2.48%
|
$30,324
$84.49 P/Share
|
|
Aug 03
2023
|
Jennifer M Kirk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,178
+7.49%
|
-
|
|
Aug 03
2023
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,965
-11.29%
|
$1,509,060
$84.49 P/Share
|
|
Aug 03
2023
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,165
+10.25%
|
-
|
|
Aug 03
2023
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,919
-11.33%
|
$497,196
$84.49 P/Share
|
|
Aug 03
2023
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,105
+11.97%
|
-
|
|
Jul 31
2023
|
Jennifer M Kirk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,849
+17.56%
|
-
|
|
Jul 31
2023
|
Robert John White EVP & Pres. Medical Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
9,116
+16.49%
|
-
|
|
Jul 31
2023
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
9,686
+22.36%
|
-
|
|
Jul 31
2023
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
8,547
+14.0%
|
-
|
|
Jul 31
2023
|
Gregory L Smith EVP Global Ops & Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
26,209
+32.21%
|
-
|
|
Jul 31
2023
|
Michael Marinaro EVP & President, Surgical OU |
BUY
Grant, award, or other acquisition
|
Direct |
6,837
+18.62%
|
-
|
|
Jul 31
2023
|
Sean Salmon EVP & President Cardiovascular |
BUY
Grant, award, or other acquisition
|
Direct |
9,686
+17.3%
|
-
|
|
Jul 31
2023
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
BUY
Grant, award, or other acquisition
|
Direct |
7,977
+16.35%
|
-
|
|
Jul 31
2023
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,535
+22.01%
|
-
|
|
Jul 31
2023
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
34,185
+19.73%
|
-
|
|
Jul 14
2023
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Open market or private sale
|
Direct |
2,000
-7.71%
|
$174,000
$87.97 P/Share
|
|
Jul 10
2023
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Open market or private sale
|
Direct |
5,514
-5.88%
|
$474,204
$86.58 P/Share
|
|
Jul 10
2023
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Exercise of conversion of derivative security
|
Direct |
5,514
+5.52%
|
$303,270
$55.32 P/Share
|
|
May 02
2023
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-0.42%
|
$15,210
$90.23 P/Share
|
|
May 02
2023
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-0.23%
|
$15,210
$90.23 P/Share
|
|
May 02
2023
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-1.22%
|
$15,210
$90.23 P/Share
|
|
May 02
2023
|
Richard H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-0.15%
|
$15,210
$90.23 P/Share
|